Weekly nab-paclitaxel in metastatic breast cancer - Summary and results of an expert panel discussion

Keyphrases

• Panel Discussion 100%
• Expert Panel 100%
• Metastatic Breast Cancer 100%
• Nab-paclitaxel 100%
• Taxanes 40%
• Clinical Practice 20%
• Solvent-free 20%
• Monotherapy 20%
• Transport Properties 20%
• Clinical Data 20%
• Clinical Efficacy 20%
• Breast Cancer 20%
• Clinical Evidence 20%
• Hydrophobicity 20%
• Paclitaxel 20%
• Human Serum Albumin 20%
• Colloidal Suspension 20%
• Advisory Board 20%
• Metastatic Disease 20%
• Albumin 20%
• Line of Therapy 20%
• Weekly Schedule 20%
• Corticosteroids 20%
• Premedication 20%
• Anthracyclines 20%
• Group of Eight 20%
• Board Meetings 20%
• Weekly Administration 20%
• Recommended Dose 20%
• Physiological Transport 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Paclitaxel 100%
• Metastatic Breast Cancer 100%
• Taxane 40%
• Hydrophobicity 20%
• Side Effect 20%
• Metastasis 20%
• Breast Cancer 20%
• Human Serum Albumin 20%
• Monotherapy 20%
• Anthracycline 20%
• Transcytosis 20%